Biomerica, Inc. is a biomedical technology firm that designs and markets diagnostic and therapeutic products aimed at improving health outcomes and lowering healthcare costs. The company focuses its research and development efforts on gastrointestinal and inflammatory diseases. It develops in-vitro diagnostics for use in clinical-lab, point-of-care, and at-home settings, covering a broad range of test areas including anaemia, bone & mineral metabolism, colorectal disease, diabetes, endocrinology, food intolerance, gastrointestinal, kidney disease, men’s health and women’s health.

Key products and services

• Diagnostic test kits for clinical laboratories (in-vitro diagnostics)
• Point-of-care diagnostics devices and systems
• At-home testing solutions
• Therapeutic products (in development) for gastrointestinal and inflammatory diseases
• Contract development and manufacturing services for diagnostics manufacturers

With a portfolio of more than 80 diagnostic products and over 100 patents filed, Biomerica combines engineering, manufacturing and regulatory expertise to support diagnostic innovation worldwide. Its integrated model—spanning from assay design through global distribution—positions it as a capable partner for healthcare companies seeking reliable development and manufacturing support.